BfArM President: Real-World Data & Randomized Trials “Compatible, Complementary Tools”

Early access, real-world evidence and data generation, and Brexit are just a few of the high-level challenges facing European health care and regulatory systems. DIA’s EuroMeeting 2017 will discuss ways to approach these challenges in forums such as Major European Regulatory Science Challenges, which will be co-chaired by Dr. Karl Broich, President, Federal Institute for Drugs and Medical Devices in Germany (BfArM). “You will learn about early access to innovative products, that we have all our regulatory tools available. However, you will see as well that we have to improve our methodology and find ways into real-world evidence in addition to our usual randomized, controlled trials,” explains Dr. Broich. “They will complement each other in future clinical development plans, particularly if we are discussing early access for patients.” To learn more, register for our DIA EuroMeeting 2017 in Glasgow!